Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage

Journal of Physiology

Volumn 588, Issue 6, 2010, Pages 995-1009

  Howard, Alison ^a   Tahir, Imran ^a   Javed, Sajid ^a   Waring, Sarah M ^a   Ford, Dianne ^a   Hirst, Barry H ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE SYNTHASE; GLYCINE; GLYCINE TRANSPORTER 1; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE;

AMINO ACID TRANSPORT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; INTRACELLULAR MEMBRANE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; BIOACCUMULATION; CELL DIFFERENTIATION; CELL LEVEL; CELL MEDIATED CYTOTOXICITY; CELL VIABILITY; CONCENTRATION (PARAMETERS); ENZYME SYNTHESIS; HUMAN TISSUE; IMMUNE RESPONSE; INTESTINE EPITHELIUM CELL; OXIDATION; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CACO-2 CELLS; CELL LINE; GLUTATHIONE; GLYCINE; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; INTESTINAL MUCOSA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; TERT-BUTYLHYDROPEROXIDE;

EID: 77951711645     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.186262     Document Type: Article

References (61)

1. Aki T, Egashira N, Yamauchi Y, Hama M, Yano T, Itoh Y, Yamada T, Oishi R. Protective effects of amino acids against gabexate mesilate-induced cell injury in porcine aorta endothelial cells. J Pharmacol Sci 2008, 107:238-245.
2. Allen CN, Harpur ES, Gray TJB, Hirst BH. Toxic effects of non-steroidal anti-inflammatory drugs in a human intestinal epithelial cell line (HCT-8), as assessed by the MTT and neutral red assays. Toxicology in Vitro 1991, 5:183-191.
3. Atkinson BN, Bell SC, De Vivo M, Kowalski LR, Lechner SM, Ognyanov VI, Tham CS, Tsai C, Jia J, Ashton D, Klitenick MA. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Mol Pharmacol 2001, 60:1414-1420.
4. Christie GR, Ford D, Howard A, Clark MA, Hirst BH. Glycine supply to human enterocytes mediated by high-affinity basolateral GLYT1. Gastroenterology 2001, 120:439-448.
5. Deters M, Siegers CP, Strubelt O. Influence of glycine on the damage induced in isolated perfused rat liver by five hepatotoxic agents. Toxicology 1998, 128:63-72.
6. Dickson RC, Bronk SF, Gores GJ. Glycine cytoprotection during lethal hepatocellular injury from adenosine triphosphate depletion. Gastroenterology 1992, 102:2098-2107.
7. Diestel CF, Marques RG, Lopes-Paulo F, Paiva D, Horst NL, Caetano CE, Portela MC. Role of L-glutamine and glycine supplementation on irradiated colonic wall. Int J Colorectal Dis 2007, 22:1523-1529.
8. Dong Z, Venkatachalam MA, Weinberg JM, Saikumar P, Patel Y. Protection of ATP-depleted cells by impermeant strychnine derivatives: implications for glycine cytoprotection. Am J Pathol 2001, 158:1021-1028.
9. Frank A, Rauen U, de Groot H. Protection by glycine against hypoxic injury of rat hepatocytes: inhibition of ion fluxes through nonspecific leaks. J Hepatol 2000, 32:58-66.
10. Gundersen RY, Vaagenes P, Breivik T, Fonnum F, Opstad PK. Glycine - an important neurotransmitter and cytoprotective agent. Acta Anaesthesiol Scand 2005, 49:1108-1116.
11. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, Sadri N, Yun C, Popko B, Paules R, Stojdl DF, Bell JC, Hettmann T, Leiden JM, Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 2003, 11:619-633.
12. Hashim A, Mulcahy G, Bourke B, Clyne M. Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells. Infect Immun 2006, 74:99-107.
13. Howard A, Goodlad RA, Walters JR, Ford D, Hirst BH. Increased expression of specific intestinal amino acid and peptide transporter mRNA in rats fed by TPN is reversed by GLP-2. J Nutr 2004, 134:2957-2964.
14. Iijima S, Shou J, Naama H, Calvano SE, Daly JM. Beneficial effect of enteral glycine in intestinal ischemia/reperfusion injury. J Gastrointest Surg 1997, 1:53-60.
15. Ikejima K, Iimuro Y, Forman DT, Thurman RG. A diet containing glycine improves survival in endotoxin shock in the rat. Am J Physiol Gastrointest Liver Physiol 1996, 271:G97-103.
16. Jackson AA. Blood glutathione in severe malnutrition in childhood. Trans R Soc Trop Med Hyg 1986, 80:911-913.
17. Jackson AA, Gibson NR, Lu Y, Jahoor F. Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein. Am J Clin Nutr 2004, 80:101-107.
18. Jacob T, Ascher E, Hingorani A, Kallakuri S. Glycine prevents the induction of apoptosis attributed to mesenteric ischemia/reperfusion injury in a rat model. Surgery 2003, 134:457-466.
19. Kallakuri S, Ascher E, Pagala M, Gade P, Hingorani A, Scheinman M, Mehraein K, Jacob T. Protective effect of glycine in mesenteric ischemia and reperfusion injury in a rat model. J Vasc Surg 2003, 38:1113-1120.
20. Katayama S, Mine Y. Antioxidative activity of amino acids on tissue oxidative stress in human intestinal epithelial cell model. J Agric Food Chem 2007, 55:8458-8464.
21. Krzywanski DM, Dickinson DA, Iles KE, Wigley AF, Franklin CC, Liu RM, Kavanagh TJ, Forman HJ. Variable regulation of glutamate cysteine ligase subunit proteins affects glutathione biosynthesis in response to oxidative stress. Arch Biochem Biophys 2004, 423:116-125.
22. Leblond J, Hubert-Buron A, Bole-Feysot C, Ducrotte P, Déchelotte P, Coëffier M. Regulation of proteolysis by cytokines in the human intestinal epithelial cell line HCT-8: role of IFNγ. Biochimie 2006, 88:759-765.
23. Lee MA, McCauley RD, Kong SE, Hall JC. Pretreatment with glycine reduces the severity of warm intestinal ischemic-reperfusion injury in the rat. Ann Plast Surg 2001, 46:320-326.
24. Lee MA, McCauley RD, Kong SE, Hall JC. Influence of glycine on intestinal ischemia-reperfusion injury. J Parenter Enteral Nutr 2002, 26:130-135.
25. Ligumsky M, Sestieri M, Okon E, Ginsburg I. Antioxidants inhibit ethanol-induced gastric injury in the rat. Role of manganese, glycine, and carotene. Scand J Gastroenterol 1995, 30:854-860.
26. Lu SC. Regulation of glutathione synthesis. Molecular Aspects of Medicine 2009, 30:42-59.
27. Luck SN, Bennett-Wood V, Poon R, Robins-Browne RM, Hartland EL. Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli. Infect Immun 2005, 73:3063-3071.
28. Luntz SP, Unnebrink K, Seibert-Grafe M, Bunzendahl H, Kraus TW, Buchler MW, Klar E, Schemmer P. HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]. BMC Surg 2005, 5:18.
29. Mangino JE, Kotadia B, Mangino MJ. Characterization of hypothermic intestinal ischemia-reperfusion injury in dogs. Effects of glycine. Transplantation 1996, 62:173-178.
30. Marion R, Coeffier M, Lemoulan S, Gargala G, Ducrotte P, Dechelotte P. L-Arginine modulates CXC chemokines in the human intestinal epithelial cell line HCT-8 by the NO pathway. Biochimie 2005, 87:1048-1055.
31. Marsh DC, Vreugdenhil PK, Mack VE, Belzer FO, Southard JH. Glycine protects hepatocytes from injury caused by anoxia, cold ischemia and mitochondrial inhibitors, but not injury caused by calcium ionophores or oxidative stress. Hepatology 1993, 17:91-98.
32. Martensson J, Jain A, Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci U S A 1990, 87:1715-1719.
33. Merchant NB, Rogers CM, Trivedi B, Morrow J, Coffey RJ. Ligand-dependent activation of the epidermal growth factor receptor by secondary bile acids in polarizing colon cancer cells. Surgery 2005, 138:415-421.
34. Merendino N, Dwinell MB, Varki N, Eckmann L, Kagnoff MF. Human intestinal epithelial cells express receptors for platelet-activating factor. Am J Physiol Gastrointest Liver Physiol 1999, 277:G810-818.
35. Miller GW, Lock EA, Schnellmann RG. Strychnine and glycine protect renal proximal tubules from various nephrotoxicants and act in the late phase of necrotic cell injury. Toxicol Appl Pharmacol 1994, 125:192-197.
36. Morales A, Garcia-Ruiz C, Miranda M, Mari M, Colell A, Ardite E, Fernandez-Checa JC. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of γ-glutamylcysteine synthetase. J Biol Chem 1997, 272:30371-30379.
37. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
38. Nissim I, Hardy M, Pleasure J, States B. A mechanism of glycine and alanine cytoprotective action: stimulation of stress-induced HSP70 mRNA. Kidney Int 1992, 42:775-782.
39. Pinto M, Robine-Leon S, Appay M, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simon-Assam P, Haffen K. Enterocyte-like differentiation and polarisation of the human colon carcinoma cell line Caco-2 in culture. Biol Cell 1983, 47:323-330.
40. Rajendra S, Lynch JW, Schofield PR. The glycine receptor. Pharmacol Ther 1997, 73:121-146.
41. Reeds PJ, Burrin DG, Stoll B, van Goudoever JB. Role of the gut in the amino acid economy of the host. Nestlé Nutrition Institute Workshop Series: Clinical & Performance Program vol. 3, Proteins, Peptides and Amino Acids in Enteral Nutrition 2000, 25-46. Fürst P, Young V, In, ed, pp, Vevey/S. Karger AG, Basel
42. Rogers TJ, Paton AW, McColl SR, Paton JC. Enhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli. Infect Immun 2003, 71:5623-5632.
43. Schaefer N, Tahara K, Schuchtrup S, Websky MV, Overhaus M, Schmidt J, Wirz S, Abu-Elmagd KM, Kalff JC, Hirner A, Turler A. Perioperative glycine treatment attenuates ischemia/reperfusion injury and ameliorates smooth muscle dysfunction in intestinal transplantation. Transplantation 2008, 85:1300-1310.
44. Schemmer P, Golling M, Kraus T, Mehrabi A, Mayatepek E, Herfarth C, Klar E. Extended experience with glycine for prevention of reperfusion injury after human liver transplantation. Transplant Proc 2002, 34:2307-2309.
45. Schilling T, Eder C. A novel physiological mechanism of glycine-induced immunomodulation: Na+-coupled amino acid transporter currents in cultured brain macrophages. J Physiol 2004, 559:35-40.
46. Senthilkumar R, Sengottuvelan M, Nalini N. Protective effect of glycine supplementation on the levels of lipid peroxidation and antioxidant enzymes in the erythrocyte of rats with alcohol-induced liver injury. Cell Biochem Funct 2004, 22:123-128.
47. Silva P, Rosen S, Spokes K, Epstein FH. Effect of glycine on medullary thick ascending limb injury in perfused kidneys. Kidney Int 1991, 39:653-658.
48. Sogabe K, Roeser NF, Venkatachalam MA, Weinberg JM. Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney Int 1996, 50:845-854.
49. Suh JH, Shenvi SV, Dixon BM, Liu H, Jaiswal AK, Liu RM, Hagen TM. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc Natl Acad Sci U S A 2004, 101:3381-3386.
50. Takamura Y, Fatma N, Kubo E, Singh DP. Regulation of heavy subunit chain of γ-glutamylcysteine synthetase by tumor necrosis factor-α in lens epithelial cells: role of LEDGF/p75. Am J Physiol Cell Physiol 2006, 290:C554-566.
51. Tompkins WA, Watrach AM, Schmale JD, Schultz RM, Harris JA. Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum. J Natl Cancer Inst 1974, 52:1101-1110.
52. Tormos C, Javier Chaves F, Garcia MJ, Garrido F, Jover R, O'Connor JE, Iradi A, Oltra A, Oliva MR, Saez GT. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Cancer Letters 2004, 208:103-113.
53. Tsune I, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Takei Y, Sato N. Dietary glycine prevents chemical-induced experimental colitis in the rat. Gastroenterology 2003, 125:775-785.
54. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. RESEARCH0034
55. Weinberg JM. Glutathione and glycine in acute renal failure. Ren Fail 1992, 14:311-319.
56. Weinberg JM, Varani J, Johnson KJ, Roeser NF, Dame MK, Davis JA, Venkatachalam MA. Protection of human umbilical vein endothelial cells by glycine and structurally similar amino acids against calcium and hydrogen peroxide-induced lethal cell injury. Am J Pathol 1992, 140:457-471.
57. Weinberg JM, Venkatachalam MA, Garzo-Quintero R, Roeser NF, Davis JA. Structural requirements for protection by small amino acids against hypoxic injury in kidney proximal tubules. FASEB J 1990, 4:3347-3354.
58. Xu TX, Gong N, Xu TL. Inhibitors of GlyT1 and GlyT2 differentially modulate inhibitory transmission. Neuroreport 2005, 16:1227-1231.
59. Zhang K, Weinberg JM, Venkatachalam MA, Dong Z. Glycine protection of PC-12 cells against injury by ATP-depletion. Neurochem Res 2003, 28:893-901.
60. Zhong Z, Jones S, Thurman RG. Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Physiol Gastrointest Liver Physiol 1996, 270:G332-338.
61. Zhong Z, Wheeler MD, Li X, Froh M, Schemmer P, Yin M, Bunzendaul H, Bradford B, Lemasters JJ. L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care 2003, 6:229-240.